Please login or register first to view this content.
News
NEWS
Latest News
Multi- vs Culprit-Vessel Only PCI for AMICS
Immune Globulin Therapy Linked to Heart Function Recovery in COVID-Related Multisystem Inflammatory Syndrome
Nearly a Fifth of Patients With Congenital Heart Disease Have Depression
NIH Trial Investigating Hydroxychloroquine Plus Azithromycin for COVID-19 Begins
Significant QT Prolongation Associated With Chloroquine/Hydroxychloroquine Treatment for COVID-19
Characterizing Lipid Profiles Associated with Asymptomatic Intracranial Arterial Stenosis
Pandemic Perspectives: Q&A With K. Luan Phan, MD
Antiviral Merimepodib to Be Investigated in Phase 2 Trial for COVID-19
COVID-19 Fatality Rate High for Heart Transplant Recipients
Drug News from MPR
FDA Issues Emergency Use Authorization for Point-of-Care COVID-19 Tests
Ozempic Approved to Reduce Risk of Major Adverse Cardiovascular Events
Provider Gaps Identified in Cardiopulmonary Care
Rilonacept Gets Breakthrough Therapy Status for Recurrent Pericarditis
Cardiometabolic Effects of Gender-Affirming Hormone Therapy in Transgender Youth
Oral Suspension Formulation of Amlodipine Now Available
How I Treat My Patients With Sacubitril/Valsartan for Heart Failure With Reduced Ejection Fraction
Rivaroxaban Appears Safe, Effective for Pediatric Acute VTE
Inclisiran Associated With Sustained LDL-C Reduction in ORION-3 Study
Alirocumab Approved by FDA to Reduce Serious Cardiovascular Event Risk
Want to read more?
Next post in Arrhythmia
